Financhill
Back

bluebird bio Quote, Financials, Valuation and Earnings

bluebird bio Price Quote

$8.23
-0.20 (-10.83%)
(Updated: December 21, 2024 at 5:17 AM ET)

bluebird bio Key Stats

Sell
22
bluebird bio (BLUE) is a Sell

Day range:
$7.94 - $9.80
52-week range:
$5.80 - $38.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.39
P/B ratio:
2.42%

Volume:
898.5K
Avg. volume:
576K
1-year change:
-68.07%
Market cap:
$82M
Revenue:
$29.5M
EPS:
$-35.8

How Much Does bluebird bio Make?

Data Unavailable

Is bluebird bio Growing As A Company?

Data Unavailable

bluebird bio Stock Price Performance

  • Did bluebird bio Stock Go Up Last Month?
    bluebird bio share price went up by 39.11% last month
  • Did BLUE's Share Price Rise Over The Last Year?
    BLUE share price fell by -68.07% over the past 1 year

What Is bluebird bio 52-Week High & Low?

bluebird bio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy bluebird bio?

Data Unavailable

Is bluebird bio Cash Flow Positive?

Data Unavailable

bluebird bio Return On Invested Capital

Data Unavailable

bluebird bio Earnings Date & Stock Price

  • What Is bluebird bio's Stock Price Today?
    A single share of BLUE can be purchased today for 8.43
  • What Is bluebird bio’s Stock Symbol?
    bluebird bio trades on the nasdaq under the ticker symbol: BLUE
  • When Is bluebird bio’s Next Earnings Date?
    The next quarterly earnings date for bluebird bio is scheduled on March 26, 2025
  • When Is BLUE's next ex-dividend date?
    bluebird bio's next ex-dividend date is December 22, 2024
  • How To Buy bluebird bio Stock?
    You can buy bluebird bio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

bluebird bio Competitors

  • Who Are bluebird bio's Competitors?
    Below is a list of companies who compete with bluebird bio or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Armata Pharmaceuticals Inc (ARMP)
    • Perspective Therapeutics Inc (CATX)
    • Protalix BioTherapeutics Inc (PLX)
    • Vertex Pharmaceuticals Inc (VRTX)

bluebird bio Dividend Yield

Data Unavailable

bluebird bio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 11.43%
Revenue: -14.36% -43.18%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 37.33
Upside from Last Price: 342.86%

Major Shareholders

Data Unavailable